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Abstract
The PARK7 gene encodes a protein, DJ-1, with several functions such as protection of cells from
oxidative stress, sperm maturation and fertilization, and chaperone activity. Mutations in the
PARK7 gene are associated with autosomal recessive early-onset Parkinson's disease (PD). DJ-1
has been reported to be expressed in multiple cells in the central nerve system. Here, by using both
native and denatured Western blots, we examined levels of total DJ-1 and high molecular weight
complexes of DJ-1 (HMW) in both the substantia nigra and cortex from rapidly autopsied 18 PD
and 9 non-pathological control (NPC) brains. We have discovered that the level of total DJ-1
protein is significantly reduced in the substantia nigra in brains of sporadic PD patients. Moreover,
in the PD cortex mitochondria fraction, the HMW DJ-1 complex is significantly lower than in the
NPC. These results suggest abnormal DJ-1 expression levels and DJ-1 complex changes may
contribute to PD pathogenesis.
Background
Parkinson's disease (PD), affecting 1% of the population
over 65, is one of the most common neurodegenerative
disorders characterized with selective loss of dopaminer-
gic neurons in the substantia nigra [1-3]. Although molec-
ular mechanism of disease is not fully known, studies
indicate that mitochondrial dysfunction and oxidative
stress could play a role in neuronal loss [4]. Three mutated
genes – Parkin, DJ-1, and PINK1 – implicated in mito-
chondria and oxidative stress-related survival pathways
are typically present in the brain with Parkinson's disease
(PD) with apparent autosomal recessive inheritance. Two
other genes – α -Synuclein and LRRK2 – are present in an
autosomal dominant pattern and are associated with
prominent intracellular protein inclusions [5,6]. A
number of pathogenic mutations identified in the DJ-1
gene are linked to early onset familial Parkinson's disease
(PD) [7-11]. Mechanistically, the DJ-1 protein has been
reported to be sensitive to oxidative stress and it may func-
tion as an anti-oxidant protein [12-15].
DJ-1 is a small protein composing 189 amino acids and it
is expressed in variety of tissues including brain [16,17].
Although its precise biochemical function is not fully
known, recent studies indicate that it has been involved in
many diverse biological processes including protease,
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chaperone and antioxidant activities [13,18-20]. Crystal
structure and biochemical data show that DJ-1 forms dim-
ers (37 KD) [18,20-23]. In addition to dimer formation,
DJ-1 also tends to form high molecular weight (HMW)
complexes (250–700 kD) during normal condition
[21,24-26] It is possible that DJ-1 and other DJ-1 interact-
ing proteins might form these HMW complexes. Although
presence of α-synuclein is controversial [21,24,27], Parkin
has been associated with DJ-1 HMW complex [21] How-
ever, whether the DJ-1 HMW complex remains intact in
brains with sporadic PD is not clear. Regulation of the for-
mation and distribution of the DJ-1 HMW complexes
remains largely obscure at this stage. In this study, we ana-
lyzed the levels of DJ-1 HMW complex as well as the DJ-1
protein in the substantia nigra, temporal cortex and mito-
chondria fraction from the rapidly autopsied temporal
cortex from the brains of PD patients by native and dena-
tured Western blots. We found that the total DJ-1 protein
was significantly reduced in the substantia nigra and the
DJ-1 HMW complex in the cortex mitochondria is also sig-
nificantly decreased in brains of sporadic PD patients.
These results suggest abnormal DJ-1 expression levels and
DJ-1 protein structure changes may contribute to PD
pathogenesis.
Materials and methods
Patient brain tissue samples
Rapidly autopsied brain tissue was obtained from the
Brain Donation Program, Sun Health Research Institute,
Sun City, Arizona, USA. Human tissue was collected with
informed consent from subjects or next of kin and with
ethical approval from the Sun Health Institutional Review
Board. Diagnosis of Parkinson's disease was made with
the presence of Lewy bodies and pigmented neuron loss
in the substantia nigra. Non-pathological controls (NPC)
were selected based on the absence of Lewy bodies and/or
neuron loss in the substantia nigra. Patients with auto-
somal recessive juvenile parkinsonism, a relatively rare
syndrome that shares many of the features of parkinson-
ism but without the presence of Lewy bodies or Lewy neu-
rites at autopsy [28,29], were excluded from this study.
The average age of PD patients is 80 ± 6.9 years old and
NPC is 85 ± 6.6 years old, therefore there were no signifi-
cant difference in ages between PD and NPC (Table 1).
Sample Preparation
Human brain tissues were preserved at -80°C until used.
Grey matter from the temporal cortex was cut and re-sus-
pended in re-suspension buffer (25 mM BisTris-HCl, 20%
Glycerol, pH 7.0) plus proteinase inhibitors. One-tenth of
the volume of the solubilization buffer (50 mM BisTris-
HCl, 40% Glycerol, 2% SDS) was added, and followed by
agitation at 4°C for 60 min. After centrifugation at 14000
rpm for 30 min, the supernatant was stored at -80°C.
Mitochondria purification was performed as described
previously [30]. Briefly, brain tissue was homogenized in
0.32 M sucrose, 10 mM Tris-HCl, pH7.4, and spun at 900
g for 30 min. The supernatant was transferred to another
tube and spun again at 900 g at 4°C. The mitochondria
were then collected by centrifuging at 10,000 g for 30 min.
The pellet was washed with 0.25 M sucrose three times
and finally collected by centrifugation at 6500 g for 10
min. To examine the purity of the mitochondria, we used
Western blotting to evaluate levels of mitochondria mark-
ers CoxIV (Abcam) and prohibitin (Abcam). To rule out a
possibility of contamination with other cellular organs,
we used EEA1 (BD Bioscience) as an endosome marker,
GM130 (BD Bioscience) as a Golgi marker and LAMP2
(BD Bioscience) as a lysosome marker in purified lysates.
Native and Denatured Gel electrophoresis and Western 
Blot
For native electrophoresis, samples were mixed with a 1:1
concentration of sample buffer (100 mM Tris-HCl pH6.8,
20%glycerol, 0.2% Bromophenol blue). Samples were
separated on a 6% Tris-Glycine native gel (without SDS).
For denatured electrophoresis, samples were diluted 1:1
with denaturing sample buffer (100 mM Tris-HCl pH6.8,
2.5%β-Mercapethanol, 4%SDS, 20%glycerol,
Table 1: General patient information and pathology criteria.
Group Sample Size (n) Gender (M/F) Age Average Onset Age Average Post-mortem Pathological Summary
PD 18 11/7 81 ± 6 67 ± 12 2.47 ± 0.72 hrs Diagnosis of Parkinson's disease is 
made in the presence of a clinical 
diagnosis of Parkinsonism in which 
Lewy bodies and pigmented neuron 
loss are present in the substantia 
nigra.
NPC 9 5/4 84 ± 6 2.85 ± 0.48 hrs Non-pathological controls (NPC) 
were selected based on absence of 
Lewy bodies and/or neuron loss in 
substantia nigra.Molecular Neurodegeneration 2009, 4:23 http://www.molecularneurodegeneration.com/content/4/1/23
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0.2%Bromophenol blue) and separated on a 10% stand-
ard SDS-PAGE, and then the protein was transferred to
PDVF membrane. Western blots were probed by anti-DJ-
1 polyclonal antibody DJ-1 raised against KLH-conju-
gated peptide NH2-KGAEEMETVIPVDVMRRAGCOOH
corresponding to N-terminal residues 12–30 of human
DJ-1 (1: 5,000) [21]. Blots were also probed with anti-β-
actin monoclonal antibody (Sigma) as a loading control.
For mitochondria samples, the blots were probed by an
anti-CoxIV monoclonal antibody (1: 2,000) (Abcam) as a
mitochondria loading control. Levels of high molecular
weight DJ-1 complex and total DJ-1 were normalized to β-
actin or CoxIV (for mitochondria samples).
Statistical Analysis
Optical density of HMW and total DJ-1 in the substantia
nigra, cortex and mitochondria from the cortex was ana-
lyzed and normalized to β-actin (substantia nigra, cortex)
or CoxIV (mitochondria). One Way ANOVA was com-
puted for the comparisons between PD and NPC groups.
Total and HMW levels in PD are expressed as a percentage
of (%) of NPC levels, and bars represent mean and ± SE.
Primary cell culture and Immunofluorescence
Cells from the human superior temporal cortex were iso-
lated and cultured according to our previous report [31].
The resulting cells were fixed with 4% paraformaldehyde
for 10 min and Blocked with 10% goat serum for 30 min.
Primary antibodies were applied with antibodies against β
III tubulin (TUJ1, neuronal marker, Covance, 1:800), DJ1
(Chemicon, AB9212, 1:400), GFAP (astrocyte marker,
Dako, 1:2,000), CoxIV (mitochondria marker, 1:1000).
Cells were counterstained with DAPI (SantaCruz,
1:1,000). Fluorescent-labeling 488 (green) or 594 (red)
secondary antibodies against rabbit IgG or mouse IgG
were detected (Molecular Probes, 1:1000).
Results
Edged but significant difference in total DJ-1 levels in the 
Substantia Nigra between PD patients and NP controls
Since the major pathological symptom in sporadic PD is
the presence of Lewy bodies in the substantia nigra, we
first analyzed levels of DJ-1 in this region.
The DJ-1 HMW complex and total DJ-1 protein levels in
the PD substantia nigra (n = 18) and age-matched NPC (n
= 9) substantia nigra were compared by using native and
denatured Western blotting (Fig. 1). The DJ-1 HMW com-
plex was able to be detected in the substantia nigra tissue.
After normalization to β-actin level, there was no signifi-
cant difference in DJ-1 HMW complex between PD and
NPC groups (p = 0.36) (Fig. 1B). However, though varia-
tion of total DJ-1 protein levels in PD and NPC were
largely overlapped, we found that its level in PD is lower
than NPC at an edge of significance (p = 0.047) (Fig. 1B).
Quantitative analysis revealed that total DJ-1 reactivity
was decreased by an average of 29% in PD compared to
NPC, indicating that substantia nigra DJ-1 might be
linked to PD progression.
No significant change in DJ-1 levels in the Cortex of PD 
patients
Since oxidative stress was reported in the cortex region of
sporadic PD patients [32], it would be interesting to find
out if DJ-1 plays a role in regulating such stress in the cor-
tex region. To examine whether HMW or total DJ-1 pro-
tein levels were affected in the cortex region of PD, protein
levels of DJ-1 in the PD and NPC temporal cortex grey
matter were examined by native and denatured Western
blot (Fig. 2A). Quantitative band densitometry did not
reveal any differences in the HMW complex (p = 0.22, Fig.
2B), or total DJ-1 (p = 0.42, Fig. 2B) levels between these
two groups, indicating, as a whole, that DJ-1 protein levels
in the cortex might not be related to PD phenotype.
DJ-1 Is Localized in the Mitochondria of Both Glia and 
Neuron Cells
Studies have shown that DJ-1 is involved in protection
against mitochondrial damage [14,15,33,34]. To find out
whether DJ-1 exists in the mitochondria, we isolated pri-
mary cells (both neuron and astrocytes) from normal
human brain cortex grey matter and immunostained with
anti DJ-1 antibody and anti-CoxIV antibody (mitochon-
dria marker) accompanied with glia cell marker, GFAP, or
neuron cell marker, β III-tubulin. In glia cells (Fig. 3A),
DJ-1 was widely distributed in the cytoplasm, while a por-
tion of the DJ-1 protein co-localized with the mitochon-
dria marker CoxIV (Fig. 3A), indicating that DJ-1is located
in the glial cell mitochondria. Similarly, we also found
that DJ-1 in neuronal cells is also localized to mitochon-
dria (Fig. 3B). Our results suggested that, in both glia cells
and neuron cells, a small portion of DJ-1 located in the
mitochondria and could play a role in regulating oxida-
tive stress in mitochondria, consistent with previous
reports [26].
HMW DJ-1 complex significantly decreased in PD cortex 
mitochondria
Native and denatured Western blotting was used to ana-
lyze the DJ-1 HMW complex, and total DJ-1 levels in the
mitochondria fraction purified from the temporal cortex
(Fig. 4A). After normalization to CoxIV, a mitochondria
loading control, DJ-1 HMW complex levels were found to
be significantly reduced by 39% in PD patients (*p  =
0.005, Fig. 4B). No differences were observed in total DJ-
1 levels (Fig. 4B). While total mitochondrial DJ-1 levels
are unchanged; decrease in HMW complex levels indicates
possible dissociation of DJ-1 or DJ-1 interacting proteinMolecular Neurodegeneration 2009, 4:23 http://www.molecularneurodegeneration.com/content/4/1/23
Page 4 of 9
(page number not for citation purposes)
from complex. Thus, indicating formation of HMW com-
plex might play role in protection from oxidative stress in
cortex of PD patients.
To examine the purity of the mitochondria isolated, we
used Western blotting to evaluate levels of CoxIV and pro-
hibitin, the mitochondria markers. When compared to
the brain lysate before purification, CoxIV and prohibitin
levels were found to be significantly enriched, more than
a 10 fold increase based on the densometric analysis, in
the purified mitochondria (Fig. 4C). This indicates that
the purified mitochondria, by our purification method,
are pure and enriched much more than non-purified
brain lysates. However, there is still a possibility of traces
of other organelles contaminating the results, which
could be due to some overlap in the gradient centrifuge.
To rule out such possibility, we examined the levels of
other subcellular organelles by using EEA1, an endosome
marker, GM130, a Golgi marker and LAMP2, a lysosome
marker in purified lysates. We found that the cell
organelle markers, including EEA1, GM130 and LAMP2
levels were significantly decreased (Fig. 4C), suggesting
that although there could be other trace amounts of other
organelles, the contribution of these contaminations were
minimal.
Due to the large amount of tissue required to obtain a
measurable amount of protein, which we were not able to
Substantial Nigra DJ-1 levels in PD and NPC Figure 1
Substantial Nigra DJ-1 levels in PD and NPC. A. Substantia nigra samples were prepared and native protein was sepa-
rated on a 6% Tris-glycine native gel and transferred to PDVF membrane. An equal amount of samples were mixed with dena-
turing sample buffer and separated on a 10% SDS-PAGE in parallel. Eighteen PD and 9 NPC were examined by Western blot. 
B. Spot density analysis of DJ-1 high molecular weight complex and total DJ-1 (denature gel) was normalized to β-actin level 
and indicated in percentage to NPC levels.
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obtain, substantia nigra mitochondrial fractions DJ-1 lev-
els have not yet been examined.
Discussion
DJ-1 is the third gene that has been linked to PD. Muta-
tions in the DJ-1 gene cause early onset PD with auto-
somal recessive inheritance [7-11]. In this study, we have
analyzed its levels in the more common sporadic form of
PD. We analyzed HMW DJ-1 complex and total DJ-1 pro-
tein levels in PD patients. We found significantly lower
total DJ-1 levels in the PD substantia nigra region, indicat-
ing reduction in DJ-1 protein levels might be related to the
substantia nigra pathology in PD patients. In addition, we
have shown that DJ-1 is localized in mitochondria of both
neuronal and glial cells supporting the role of DJ-1 in
mitochondrial function. When we compared the levels of
total and HMW complex of DJ-1, we have discovered sig-
nificantly decreased levels of HMW complex of DJ-1 in
mitochondrial preparation of the cortex from PD brains.
We have found that total level of DJ-1 in the substantia
nigra is decreased in PD compared to health controls (Fig.
1). However, other groups have reported either no change
or increased levels of DJ-1 in PD brain [25,35-37]. One
possibility of the discrepancy with previous groups is that
they have not investigated DJ-1 specifically in the substan-
tia nigra from PD brains. For instance, we could not
observe any change in DJ-1 protein levels in the PD fron-
tal cortex. Second, post-mortem interval (PMI) is shorter
(< 2.5 hrs) and more consistent between PD and NPC in
STG DJ-1 levels in PD and NPC Figure 2
STG DJ-1 levels in PD and NPC. A. Super temporal cortex samples were prepared and analyzed by native and denature by 
Western blot. B. Spot density analysis of DJ-1 high molecular weight complex and total DJ-1 (denatured gel) was normalized to 
β-actin level and indicated in percentage to NPC levels.
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our study compared to other groups [25,35-37], which are
critical factors. Third, we have analyzed a larger sample
group (PD n = 18, NPC n = 9) compared to others. Varia-
tion and range within each group from smaller number of
samples might affect the accuracy of the conclusion drawn
from the data.
Oxidative stress has been well-documented in the sub-
stantia nigra in PD [12-15]. Recent studies have shown
that over-expression of wild type DJ-1 in cultured human
dopaminergic cells protected the cells from death induced
by hydrogen peroxide and 6-hydroxydopamine, while
over-expressing the L166P mutant DJ-1 had no such pro-
tective effect [34]; knocking down endogenous DJ-1 ren-
dered cells susceptible to oxidative damage [34]. Also,
wild type DJ-1 inhibited the mutant A53T α-synuclein-
induced protein aggregation and cytotoxicity by increas-
ing the expression of heat shock protein 70 [34]. Accord-
ingly, our studies have shown that total levels of DJ-1 were
significantly lower in the substantia nigra region of PD
than that of NPC, implying that decreased DJ-1 levels
might account for the loss of anti-oxidation capability in
the substantia nigra region.
A recent study has also shown increased oxidative damage
in the PD cortical region [32], but little has been reported
on the subject. We proposed that DJ-1 HMW complex
could account for this anti-oxidative stress function. How-
ever, since we did not observe any significant changes in
the total DJ-1 levels in the cortex region, this suggests that
DJ-1 is localized in mitochondria in both glial and neuronal cells Figure 3
DJ-1 is localized in mitochondria in both glial and neuronal cells: A. Temporal cortex sections were double labeled 
with antibodies against DJ-1(green) and CoxIV (red). Co-localization of DJ-1 and CoxIV was showed in the merged picture. B. 
STG primary cell culture was stained with glial cell marker GFAP, followed by DJ-1 and CoxIV. Picture of DJ-1(green) and 
CoxIV (red) was merged to show co-localization of DJ-1 and mitochondria (yellow); C. STG primary cell culture was stained 
with neuron cell marker βIII-tubulin, followed by DJ-1 and CoxIV. Picture of DJ-1(green) and CoxIV (red) was merged to indi-
cate co-localization of DJ-1 and mitochondria (yellow).
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the subcellular location of DJ-1, rather than the total
amount of DJ-1, may be more important for its biological
role. Recent studies in DJ-1 subcellular localization have
identified an endogenous pool of DJ-1 in the mitochon-
drial matrix and inter-membrane space [26,38]. There-
fore, DJ-1 is an integral mitochondrial protein that may
have important functions in regulating mitochondrial
physiology [26], consistent to our result that displayed co-
localization of DJ-1 and mitochondria. Moreover, in
response to oxidative stress, DJ-1 is translocated from
cytosol to mitochondria and nucleus. DJ-1 tagged with
mitochondrial signal confers more neuro-protection
against oxidative stress when compared to WT or nuclear
tagged DJ-1 in cell assays [39]. Thus, mitochondrial local-
ization of DJ-1 is important to exert cell-protective effect
in oxidative stress condition. Interestingly, we found that
the DJ-1 HMW complex in the mitochondria fraction
extracted from the PD cortical region is significantly lower
STG grey matter mitochondria fraction DJ-1 levels in PD and NPC Figure 4
STG grey matter mitochondria fraction DJ-1 levels in PD and NPC: A. Super temporal cortex mitochondria were 
extracted and samples were prepared and analyzed by native and denatured Western blot. B. Spot density analysis of DJ-1 high 
molecular weight complex and total DJ-1 was normalized to CoxIV level and indicated in percentage to NPC levels. C. The 
Western blot study demonstrates cell compartments and related proteins in the mitochondria fraction. Specific antibodies that 
recognize specific cell compartments that are used, anti-CoxIV, anti-prohibitin are for mitochondria, anti-EEA1 is for early 
endosome antigen1 (EEA1), anti-GM130 is for Golgi Matrix protein (GM130) and anti-LAMP2 is for Lysosome-associated 
membrane protein-2 (LAMP2). When compare to the brain lysate before purification, CoxIV and prohibitin levels were found 
to be significantly elevated, more than 10 folds increased based on the densometric analysis, in the purified mitochondria. It 
shows that though there is little contamination of other cell organelles.
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than NPC. In DJ-1 HMW complex, Parkin, an E3-ubiqui-
tin ligase, has been found [21]. Moreover, oxidative stress
promotes association of Parkin and DJ-1[25]. Therefore,
reduced levels of HMW complex in mitochondria isolated
from PD cortex, may suggest reduced interaction or disso-
ciation of DJ-1 with Parkin or possibly with other proteins
as well. Additionally, recent studies also have shown that
the subunit of mitochondrial complex I in the PD cortex
region was oxidatively damaged and its function was
impaired [40], implying that HMW DJ-1 complex might
play a role in protecting the cortex mitochondria from oxi-
dative stress.
Although total DJ-1 levels were reduced in substantia
nigra, we could not observe any change in DJ-1 HMW
complex levels in sustantia nigra. On the other hand, in
cortex we could not observe any change in levels of DJ-1
HMW complex in the cortex of PD patients as well, but
when we examined mitochondria enriched preparation
from the cortex we observed a reduction in DJ-1 complex.
It could be that DJ-1 levels or distribution of DJ-1 between
HMW and dimers in mitochondria might be important
for DJ-1 function. Therefore, it would be also interesting
to examine the HMW and total DJ-1 levels in the substan-
tia nigra mitochondria. However, due to the large amount
of tissue required to prepare the mitochondria fraction,
while relatively small amount of the substantia nigra tis-
sue was available, mitochondrial fractions from substan-
tia nigra has not yet been examined until we collect
enough tissue for this study in the future.
It is worthwhile to note that large variations were seen
with each group, despite the fact that all samples were
taken from the same brain region. It is practically impos-
sible to obtain a sample set from patients in the same
cohort with identical genetic backgrounds, which would
reduce the variation. In order to clearly distinguish PD
and NPC, we categorized our patients based on patholog-
ical definitions. The inherent heterogeneity of the samples
meant that we could not rule out other genetic factors that
could affect DJ-1 levels. Future studies are anticipated to
analyze DJ-1 HMW complex and total DJ-1 in the mito-
chondria fraction of substantia nigra, when a sufficient
amount of brain tissue is available for biochemical analy-
sis, and to investigate the possible mechanisms involved.
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